191 results on '"LaBarbera, Daniel V."'
Search Results
2. HTS discovery of PARP1-HPF1 complex inhibitors in cancer
3. TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer
4. Validation of ferroptosis in canine cancer cells to enable comparative oncology and translational medicine
5. Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer
6. Advanced High-Content-Screening Applications of Clonogenicity in Cancer
7. Data from Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers
8. Data from First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer
9. Supplementary Data from First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer
10. Supplementary Data from Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers
11. Figure S1 from Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers
12. Targeting HIV-1 Protease Autoprocessing for High-throughput Drug Discovery and Drug Resistance Assessment
13. High Throughput Screen Identifies the DNMT1 (DNA Methyltransferase-1) Inhibitor, 5-Azacytidine, as a Potent Inducer of PTEN (Phosphatase and Tensin Homolog): Central Role for PTEN in 5-Azacytidine Protection Against Pathological Vascular Remodeling
14. Supplementary Tables 1-7 from Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
15. Supplementary Figure 6 from Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
16. Supplementary Figure 1 from Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
17. Supplementary Figure 2 from Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
18. Supplementary Figure 7 from Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
19. Supplementary Figure 5 from Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
20. Supplementary Figure 3 from Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
21. Supplementary Figure 4 from Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
22. AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder Cancer
23. High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes
24. Oxidative stress as a candidate mechanism for accelerated neuroectodermal differentiation due to trisomy 21
25. Response of Osteosarcoma Cell Lines to a Novel CHD1L Inhibitor
26. A High-Content Assay to Identify Small-Molecule Modulators of a Cancer Stem Cell Population in Luminal Breast Cancer
27. Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L
28. 3D Models of Epithelial-Mesenchymal Transition in Breast Cancer Metastasis: High-Throughput Screening Assay Development, Validation, and Pilot Screen
29. Progesterone-Inducible Cytokeratin 5-Positive Cells in Luminal Breast Cancer Exhibit Progenitor Properties
30. Supplemental Material, Supplemental_Material_for_Advanced_High-Throughput_Imaging_Applications_of_Clonogenicity_in_Cancer_by_Esquer_et_al. - Advanced High-Content-Screening Applications of Clonogenicity in Cancer
31. Solution kinetics of CC-1065 A-ring opening: Substituent effects and general acid/base catalysis
32. First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer
33. Drug Design Targeting T-Cell Factor-Driven Epithelial–Mesenchymal Transition as a Therapeutic Strategy for Colorectal Cancer
34. Synthesis of imidazo[1,5,4- de]quinoxalin-9-ones, benzimidazole analogues of pyrroloiminoquinone marine natural products
35. Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers
36. Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
37. Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme
38. Inhibition of α-glucosidase, α-amylase, and aldose reductase by potato polyphenolic compounds
39. The total synthesis of neoamphimedine
40. Larrea tridentata: A novel source for anti-parasitic agents active against Entamoeba histolytica, Giardia lamblia and Naegleria fowleri
41. SBI2 HCS/HCA 3D Imaging: Best Practices and Unmet Needs Colloquium
42. Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract
43. High-throughput imaging: Focusing in on drug discovery in 3D
44. Novel Microtubule-Targeting 7-Deazahypoxanthines Derived from Marine Alkaloid Rigidins with Potent in Vitro and in Vivo Anticancer Activities
45. Abstract LB-077: Topoisomerase IIα mediates TCF-dependent epithelial-mesenchymal transition in colon cancer
46. Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells
47. SBI2 HCS/HCA 3D Imaging: Best Practices and Unmet Needs Colloquium.
48. ChemInform Abstract: The Synthesis of Vinylogous Amidine Heterocycles.
49. Aldose Reductase Inhibition Prevents Endotoxin-Induced Inflammatory Responses in Retinal Microglia
50. Live Multicellular Tumor Spheroid Models For High-Content Imaging and Screening In Cancer Drug Discovery
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.